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This study was conducted to determine the antifungal activity of the metabolites from
Streptomyces sp. 3–10, and to purify and identify the metabolites. Meanwhile, the
taxonomic status of strain 3–10 was re-evaluated. The cultural filtrates of strain 3–10
in potato dextrose broth were extracted with ethyl acetate. The resulting crude extract
at 1 and 5µg/ml inhibited growth of 22 species in 18 genera of plant pathogenic
fungi and Oomycetes, accounting for 92% of the total 24 tested species, suggesting
that it has a wide antifungal spectrum. Two compounds were purified from the crude
extract and were identified as reveromycins A and B, which demonstrated high antifungal
activity against Botrytis cinerea, Mucor hiemails, Rhizopus stolonifer, and Sclerotinia
sclerotiorum under acidic pH conditions. Both the crude extract and reveromycin A from
strain 3–10 at 10, 50, and 100µg/ml showed high efficacy in suppression of strawberry
fruit rot caused by the above-mentioned four pathogens. The efficacy was comparable
to that of corresponding commercial fungicides (pyrimethanil, captan, dimetachlone)
used inmanagement of these pathogens. Morphological, physiological, and phylogenetic
characterization showed that strain 3–10 is closely related to Streptomyces yanglinensis
1307T, representing a novel phylotype in that species. This study reported a new strain
with reveromycins-producing capability. The finding is important for further exploitation
of reveromycins for agricultural use.
Keywords: Streptomyces sp. 3–10, reveromycins, plant pathogenic fungi, strawberry, antifungal activity, biological
control
INTRODUCTION
Streptomyces species (Order: Streptomycetales, family: Streptomycetaceae) are Gram-positive,
filamentous, and spore-producing actinobacteria with high G + C content in their genomes. They
are generally regarded as pharmaceutically important biological resources, because many species
of Streptomyces can produce various physiologically active metabolites, including antibiotics,
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antimicrobial enzymes, antioxidants, as well as
anti-inflammatory and anti-tumor compounds. It is estimated
that up to 80% bioactive metabolites are produced by species of
Streptomyces in Streptomycetales (Bérdy, 2012).
Streptomyces as well as other actinobacteria widely live or
dwell in various terrestrial environments, including soil, plant,
and air dust (Kettleson et al., 2013; Guo et al., 2015; Supong et al.,
2016). While a few species of Streptomyces are plant pathogens
(e.g., S. scabies caused potato scabies), majority of Streptomyces
species live as saprophytes in soil or live as endophytes in
plant tissues. The non-pathogenic Streptomyces usually produce
beneficial effects on plant growth either through providing
plants with nutrients from degradation of complex biological
polymers like cellulose and chitin in soil (Brzezinska et al.,
2013), or through secretion of plant hormones like indole-3-
acetic acid, gibberellic acid, and zeatine (Solans et al., 2011).
Meanwhile, many species of Streptomyces have been found to
be capable of suppressing growth, development, and/or survival
of plant pathogens (fungi, bacteria, nematodes, viruses) through
diverse mechanisms, including production of antibiotics and
antimicrobial enzymes (Anitha and Rabeeth, 2010; Zacky and
Ting, 2013; Mander et al., 2016), hyperparasitism (Chen et al.,
2016), and induction of plant resistance response (Conn et al.,
2008; Lehr et al., 2008; Kurth et al., 2014). Therefore, Streptomyces
species are important resources of biofungicides or biofertilizers
for agricultural use.
Attempts to use Streptomyces species to control plant diseases
can be traced back to 1927, whenMillard and Taylor (1927) found
that Streptomyces praecox (an obligate saprophyte, formerly
known as Actinomyces praecox) effectively suppressed potato
scabies when it was applied in soil either alone or together with
green manures. Streptomycin produced by S. griseus was the first
antibiotic successfully used for control of Erwinia amylovora, the
causal agent of pear fire blight (Beer et al., 1984). Since then,
extensive studies have been carried out to exploit Streptomyces
as biofungicides and/or biofertilizers. Many Streptomyces species
have been successfully developed into commercial biofungicides
either based on their live spores such as Mycostop R© (Minuto
et al., 2006) and Rhizovit R© (Berg et al., 2010), or based on
their bioactive metabolites such as blasticidin S, kasugamycin,
polyoxins, and validamycins (Kim and Hwang, 2007). Due
to these successful applications, discovering new Streptomyces
strains and identifying novel antibiotics from Streptomyces
species continue to be a hot and attractive research area. Many
novel antibiotics such as bafilomycin K produced by Streptomyces
flavotricini Y12-26 (Zhang et al., 2011), elaiomycins B produced
by Streptomyces sp. BK190 (Kim et al., 2011) and novonestmycins
produced by S. phytohabitans (Wan et al., 2015) are being
evaluated as new biofungicides.
Reveromycins are the antibiotics first isolated from the
cultures of Streptomyces reveromyceticus SN-593 in the early
1990s (Osada et al., 1991). Reveromycin A showed inhibitory
effect on growth and proliferation of the human pathogen
Candida albicans and the human cancer cell lines KB and
K562 (Osada et al., 1991). Osada et al. (1991) indicated that
reveromycin A had antifungal activity against plant pathogenic
fungi. However, they did not provide the detailed information
about the plant pathogenic fungi inhibited by reveromycin A
in that report (Osada et al., 1991). Therefore, whether or not
reveromycin A and other reveromycins can be used to control
plant fungal diseases remains unknown.
Wan et al. (2008) isolated an antagonistic strain (F-1) of
S. platensis from a healthy leaf of rice (Oryza sativa L.). They
found that S. platensis F-1 is an effective biocontrol agent for
suppression of many plant pathogenic fungi, including Botrytis
cinerea, Rhizoctonia solani, and Sclerotinia sclerotiorum, the
causal agents of tomato gray mold, rice sheath blight, and
Sclerotinia stem rot of oilseed rape, respectively (Wan et al.,
2008). In order to improve the antifungal activity of S. platensis
F-1, Che (2011) conducted a study to mutate the wild type strain
F-1 by combined treatments of the spores of strain F-1 with UV-
C and LiCl. A putative mutant named strain 3–10 was found
to have enhanced antifungal activity by approximately 100 times
compared to that of the original strain F-1 (Che, 2011). However,
the chemical identity of the antifungal metabolites produced by
the putative mutant strain 3–10 remains unknown. Moreover,
strain 3–10 differed greatly from the original strain F-1 in colony
morphology on potato dextrose agar, implying that it may not
be derived from S. platensis F-1 (Che, 2011). Therefore, the
taxonomic status of strain 3–10 needs to be clarified.
The objectives of this study are: (i) to determine the antifungal
spectrum of the crude extract from the cultures of Streptomyces
sp. 3–10; (ii) to purify and identify the antifungal metabolites
produced by Streptomyces sp. 3–10; (iii) to evaluate the efficacy
of the metabolites from strain 3–10 in suppression of strawberry
fruit rot caused by B. cinerea,Mucor hiemails, Rhizopus stolonifer,
and S. sclerotiorum; and (iv) to clarify the taxonomic status of
Streptomyces sp. 3–10.
MATERIALS AND METHODS
Microbial Species and Cultural Media
Five species of bacteria and 24 species of fungi and Oomycetes
were used in this study and their origins were listed in Table
S1. Among these microbial species, Streptomyces sp. 3–10 was
used for production of antifungal metabolites. It was isolated
from a culture containing spores of S. platensis F-1 jointly treated
by UV-irradiation and LiCl (Che, 2011). Aspergillus niger A-1
(a soil saprophyte) was used as indicator in bioassays to detect
the antifungal activity of the metabolites of strain 3–10 (Shakeel
et al., 2016). The remaining two species of Oomycetes, four
species of bacteria, and 21 species of fungi were used to test
the antimicrobial spectrum of the metabolites of Streptomyces sp.
3–10.
A total of 22 cultural media (BM, CDM, GA, GS-1, ISM, ISP-1
to ISP7, ISP-9, KB, NA, NB, OCD, PDA, PDB, SDM, TDM, and
TYM) were used in this study. The full names of these media and
their ingredient compositions were listed in Table S2.
Preparation of the Crude Extract
Spore suspension (1 × 108 spores/ml) of Streptomyces sp. 3–10
was inoculated in 250-ml Erlenmeyer flasks each containing 100
ml potato dextrose broth (PDB), 1 ml spore suspension per
flask. The flasks were incubated on a rotary shaker (150 rpm)
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at 28◦C for 3 days for production of antifungal metabolites. The
culture supernatant was collected by centrifugation at 6,000 ×
g for 10 min, and then extracted with ethyl acetate. The ethyl
acetate phase was then dried by vacuum using R-250 Rotavapor R©
(BUCHI Corporation, New Castle, USA) at 37◦C and, a kind of
brownish colloidal substance was obtained. It was treated as the
crude extract of the antifungal metabolites of Streptomyces sp.
3–10.
Determination of the Antimicrobial
Spectrum of the Crude Extract
Inhibition of fungi and Oomycetes was done using the PDA-
amendment method. The crude extract (CE) dissolved in
methanol at 12.5 mg/ml (w/v) was used as stock solution, which
was then amended to PDA in Petri dishes (9 cm diameter,
20 ml per dish) to the final concentrations of 1 or 5µg/ml.
PDA amended with methanol alone (0.2%, v/v) was treated as
control. Mycelial agar plugs (5mmdiameter) were removed from
the margin area of the actively-growing colonies of the target
organisms, and inoculated on the PDA amended with either the
crude extract or methanol alone, one mycelial plug per dish, and
three dishes (as three replicates) for each treatment. The resulting
cultures were incubated at 20◦C, 25◦C, or 28◦C for 1–7 days
depending on the mycelial growth rates of the target organisms
(Table 1). Diameter of the colony in each dish was measured.
Inhibition of mycelial growth (IMG) was calculated using the
formula: IMG (%) = (DCK − DCE)/DCK × 100, where the DCK
and DCE represent the colony diameters in the treatments of
control (CK) and CE, respectively.
Inhibition of the bacteria by the CE of Streptomyces sp. 3–10
was done using the agar diffusion method (Bonev et al., 2008).
The four investigated bacteria (Table S1) were separately shake-
incubated at 28◦C (150 rpm) in nutrient broth for 48 h. Then,
aliquots (100µl) of the liquid culture of each bacterium were
evenly spread on the nutrient agar in Petri dishes (9 cm diameter,
20 ml medium per dish). Sterilized stainless-steel Oxford cups
(10 × 6 × 8mm, height × inner diameter × outer diameter)
were placed in the dishes, three cups per dish and three dishes for
each bacterium. The three concentrations (10, 50, and 100µg/ml)
of the CE of Streptomyces sp. 3–10 were pipetted into the three
Oxford cups in each dish, respectively, 200µl per cup. For the
control treatment, three Oxford cups in a bacteria-inoculated
Petri dish were loaded with 1% methanol (v/v), 200µl per cup.
The cultures were incubated at 28◦C for 48 h and formation
of the clear zones around the cups was used as an indicator of
antibacterial activity.
Suppression of Fungal Spore Germination
by the Crude Extract
Rhizopus stolonifer and Botrytis cinerea were incubated on PDA
at 20◦C for 3 and 7 days, respectively. Spores of R. stolonifer
(sporangiospores) and B. cinerea (conidia) were harvested from
the respective cultures by washing with sterile distilled water and
the spore suspensions (1 × 106 spores/ml) were then prepared.
Aliquots (100µl) of the spore suspensions were pipetted to and
evenly spread on the D-glucose agar (GA) medium amended
TABLE 1 | Antifungal spectrum of the metabolites of Streptomyces sp.
3–10 (PDA, pH 5.3).






Pythium apanidermatum 40.5 ± 2.8 73.2 ± 0.9 20◦C at 4 dpia
Pythium ultimum 20.1 ± 1.7 48.2 ± 0.5 20◦C at 1 dpi
ZYGOMYCOTA
Mucor hiemails 80.8 ± 2.5 100.0 20◦C at 2 dpi
Rhizopus stolonifer 91.4 ± 2.8 100.0 20◦C at 1 dpi
ASCOMYCOTA
Amphobotrys ricini 69.3 ± 0.9 83.7 ± 1.4 20◦C at 7 dpi
Alteraria alternata 38.7 ± 0.6 74.5 ± 7.5 25◦C at 5 dpi
Aspergillus flavus 84.1 ± 2.7 95.2 ± 0.6 28◦C at 3 dpi
Aspergillus niger 76.6 ± 1.3 97.5 ± 0.7 28◦C at 3 dpi
Aspergillus parasiticus 23.6 ± 7.2 45.8 ± 1.4 28◦C at 3 dpi
Bipolaris maydis 27.7 ± 8.1 52.7 ± 0.6 28◦C at 5 dpi
Botrytis cinerea 86.0 ± 0.2 97.0 ± 0.6 20◦C at 3 dpi
Colletotrichum siamense 79.8 ± 0.6 87.1 ± 1.5 28◦C at 3 dpi
Curvularia lunata 17.2 ± 2.7 85.3 ± 0.7 25◦C at 3 dpi
Drechslera graminea 82.7 ± 0.9 100.0 25◦C at 3 dpi
Fusarium graminearum 0.2 ± 0.1 1.5 ± 0.1 25◦C at 3 dpi
Fusarium moniliforme 28.9 ± 5.3 57.2 ± 4.7 25◦C at 3 dpi
Fusarium oxysporum 83.6 ± 1.0 100.0 20◦C at 5 dpi
Monilia fructigena 75.5 ± 3.3 94.3 ± 0.8 25◦C at 3 dpi
Pestalotia theae 57.5 ± 5.0 87.7 ± 2.9 25◦C at 3 dpi
Pyricularia oryzae 3.6 ± 2.5 9.4 ± 5.6 28◦C at 3 dpi
Sclerotinia minor 92.5 ± 0.3 100.0 20◦C at 2 dpi
Sclerotinia sclerotiorum 97.2 ± 0.3 100.0 20◦C at 2 dpi
BASIDIOMYCOTA
Rhizoctonia solani 16.6 ± 4.5 84.7 ± 2.4 28◦C at 3 dpi
Sclerotium rolfsii 57.1 ± 1.8 91.8 ± 0.4 28◦C at 3 dpi
adpi, days post-incubation.
with the crude extract of Streptomyces sp. 3–10 at 0 (control), 1,
5, 10, 50, and 100µg/ml, six dishes (as six replicates) for each
treatment. The cultures were incubated at 20◦C in the dark for 6,
9, and 12 h. At each time point, the number of germinated spores
among randomly-selected at least 100 spores in each culture
were counted under a compound light microscope. Additionally,
length of the germ tubes of randomly-selected 20 germinated
spores was measured in each replicate culture at 12 h post-
incubation.
Isolation of the Antifungal Metabolites
from the Crude Extract
The crude extract (10 g) of Streptomyces sp. 3–10 was dissolved
in 15 ml methanol and the solution was mixed with 15 g
60-mesh silica-gel granules (Qingdao Haiyang Chemical Co.,
Ltd., China). The mixture was then loaded as the top layer in
a chromatography column (4.5 × 80 cm, inner diameter ×
length) containing 400 g silica gel (200-mesh, Qingdao Haiyang
Chemical Co., Ltd.). The column was eluded with gradient
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chloroform/methanol solutions (from 99/1 to 0/100, v/v). The
resulting fractions were individually assayed for antifungal
activity against A. niger using the Oxford cup-agar diffusion
method described by Shakeel et al. (2016). The fractions that
had antifungal activity were combined, concentrated, and loaded
in a Sephadex LH-20 chromatography column (GE Healthcare),
which was eluded with methanol to remove impurities. The
fractions that had antifungal activity were again combined,
dried, and subjected to semi-preparative high performance
liquid chromatography (HPLC). Finally, two pure compounds,
designated as Compound Nos. 1 and 2, were obtained.
Identification of the Purified Compounds
Electrospray ionization mass spectrometric (ESI-MS) analysis
and nuclear magnetic resonance spectroscopy (NMR) were used
to determine the chemical structure of the two pure compounds
from Streptomyces sp. 3–10. The ESI-MS analysis was done on a
Waters ACQUITY UPLC H-Class system coupled to the XEVO
TQ-S tandem quadrupole (Waters Cooperation, Milford, MA,
USA). The compounds were separately dissolved in methanol
to the final concentration of 1µg/ml. An aliquot (1µl) of
each solution was injected into the instrument. The operating
parameters were set as: capillary voltage at 1.0 kV, cone voltage
at 30 kV, Z-spray source temperature at 100◦C, desolvation
temperature (N2) at 400
◦C, desolvation gas flow at 800 L/h,
mass range of m/z from 50 to 1,200. The mass spectra were
collected both in the positive mode and in the negative mode,
and compared with those in Chapman Combined Chemical
Dictionary on CD-ROM version 6.1 (Chapman and Hall, 2003)
for determination of the chemical identity of the compounds.
Moreover, synthetic reveromycin A (purity > 98%) purchased
from Abcam Trading (Shanghai) Co. Ltd. (Shanghai, China) was
used as a reference chemical in the UV-Vis spectrum analysis on
Waters ACQUITY UPLC H-Class system.
In the NMR analysis, the two pure compounds were
dissolved in methanol-d4 (CD3OD, Sigma-Aldrich
R©), and were
then determined in a 400 MR DD2 spectrometer (Agilent
Technologies, USA) for spectra of 1H-NMR and 13C-NMR.
Tetramethylsilane (TMS) was used as the internal standard in the
NMR analysis.
Determination of the Content of
Reveromycin A in the Crude Extract
Synthetic reveromycin A (purity> 98%) purchased from Abcam
Trading (Shanghai) Co. Ltd. was used as standard in quantitative
determination of the content of reveromycin A in the CE from
strain 3–10. Five solutions of the synthetic reveromycin A with
the concentrations of 0.08, 0.16, 0.31, 0.63 and 1.25µg/ml in
methanol were prepared. An aliquot (1µl) of each solution of
the synthetic reveromycin A or the solution of the CE of strain
3–10 at 3.125µg/ml was injected into Waters ACQUITY UPLC
H-Class system. The peak area for reveromycin A in each solution
sample was measured. A standard curve was plotted based on
the peak areas for the solutions of the synthetic reveromycin
A and the concentrations of those solutions. The content of
reveromycin A in the CE of strain 3–10 was then calculated
based on that standard curve. The quantitative determination
was repeated for three times.
Antifungal Activity of the Purified
Compounds
The purified compounds were separately dissolved in methanol
to 10 mg/ml (w/v) as stock solutions, which were used in
the following two trials, a mycelial growth trial and a spore
germination trial. In the mycelial growth trial, the stock solution
of each compound was amended in PDA, which was adjusted
to pH 4.5, 5.5, or 7.0 with 1 mol/L HCl or 1 mol/L NaOH. The
final concentrations in PDA ranged from 0.3125 to 50.0µg/ml for
Compound No. 1, and from 0.3125 to 100µg/ml for Compound
No. 2 (Table S3). Meanwhile, methanol solution (0.2%, v/v) was
added to PDA at pH 4.5, 5.5, or 7.0 as controls. Mycelial agar
plugs of B. cinerea, M. hiemails, R. stolonifer, and S. sclerotiorum
(5 mm diameter) were individually inoculated on PDA, three
dishes for each treatment (fungus× compound× concentration
× pH). The cultures were incubated at 20◦C in the dark for
1 day for R. stolonifer, and for 3 days for the other three
fungi. The colony diameter was measured and the percentage
value of inhibition of mycelial growth (IMG) under each pH
was calculated using the formula mentioned above. EC50-values
(effective concentrations that gave 50% inhibition) for each
compound under each pHwere estimated based on the IMG data
and the concentrations of that compound applied in PDA (Van
Ewijk and Hoekstra, 1993).
In the spore germination trial, the stock solution of each
compound was amended in GA with Ph-values of 4.5, 5.5, or
7.0. The final concentrations in GA ranged from 0.0625 to
50.0µg/ml for Compound No. 1, and from 0.3125 to 100µg/ml
for Compound No. 2 (Table S3). Meanwhile, methanol solution
(0.2%, v/v) was added to GA with pH 4.5, 5.5, and 7.0 as controls.
Aliquots (100µl) of the spore suspension (1 × 106 spores/ml)
of B. cinerea, M. hiemails, or R. stolonifer were pipetted on GA
alone or on GA amended with a purified compound, three dishes
for each treatment (fungus× compound× concentration× pH).
The cultures were incubated at 20◦C for 12 h. Spore germination
in each culture was observed under light microscope. Percent
inhibition of spore germination (ISG) by each compound under
each pH was calculated using the formula: ISG (%) = (PCK–
PC)/PCK × 100, where the PCK and PC represent the percentages
of germinated spores in the treatments of control (CK) and a pure
compound, respectively. Finally, EC50-values for each compound
under each pH were estimated based on the ISG data and the
concentrations of that compound applied in GA (Van Ewijk and
Hoekstra, 1993).
Control of Strawberry Fruit Rot by
Antifungal Metabolites from Strain 3–10
Mature strawberries (Fragaria × ananassa cultivar “Jing Yu”)
of similar size (3.0–3.5 × 2.0–2.5 cm, length × width, 16–
18 g per berry) were collected from strawberry plants grown in
a plastic tunnel. They were surface sterilized in 70% ethanol
(v/v) for 1 min, followed by washing in sterile distilled water
and blotting on sterilized paper towels to remove the excess
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water on the fruit surface. Finally, they were placed in glass
Petri dishes (9 cm diameter), six berries per dish. For each
pathogen, there were 10 treatments, including one negative
control treatment with 1% methanol (v/v), three CE treatments
with the concentrations of 10, 50, and 100µg/ml (pHs at 5.4, 4.3,
and 4.2, respectively), three treatments of reveromycin A (from
strain 3–10) with the concentrations at 10, 50, and 100µg/ml (pH
at 4.5), and three fungicide treatments (positive controls) with
the concentrations of an appropriate fungicide (either captan,
pyrimethanil, or dimetachlone) at 10, 50, and 100µg a.i./ml.
Captan (3a, 4, 7, 7a-tetrahydro-2-[(trichloromethyl) thio]-1 H-
isoindole-1,3(2H)-dione) was used as the positive control for the
pathogens M. hiemails and R. stolonifer, whereas pyrimethanil
(2-anilino-4,6-dimethylpyrimidine) and dimetachlone [N-(3,5-
dichlorophenyl) succinimide] were used as positive controls
for the pathogens B. cinerea and S. sclerotiorum, respectively.
Both captan (50% wettable powder) and pyrimethanil (80%
water dispersible granule) were purchased from Hebei Guan
Long Agrichemical Co. Ltd. (Hengshui, China). Dimetachlone
(40% wettable powder) was purchased from Zhejiang SPACE
Agrichemical Co. Ltd. (Wenzhou, China).
The six strawberries in a Petri dish were immerged for 1 min
either in the 1% methanol solution, or in a solution containing
either the CE, reveromycin A or a fungicide. Then, they were
maintained in a laminar flow hood for 15–30 min, re-placed
in the dish, and inoculated with one of the four pathogens. B.
cinerera,M. hiemails, andR. stoloniferwere spray-inoculated with
the spore suspensions (1 × 106 spores/ml) amended with 0.5%
D-glucose (w/v), approximately 10 ml spore suspension on the
six strawberries in a Petri dish. S. sclerotiorum was inoculated
with mycelial agar plugs (5 mm diameter), one mycelial agar
plug on each berry. The dishes with the treated strawberries
were placed in plastic boxes (80 × 60 × 50 cm, length × width
× height), which were individually covered with a transparent
plastic film (0.1 mm thick, Gold Mine Plastic Industry Ltd.,
Jiangmen, China) to maintain the high humidity condition. The
boxes were placed in a growth room at 20◦C under the light
regime of 12-h light/12-h dark. After incubation for 3 and 5 days
for the inoculation treatments with R. stolonifer andM. hiemails,
respectively, and for 7 days for the inoculation treatments with B.
cinerea, and S. sclerotiorum, disease severity on the strawberries
was individually rated using a numeric scale from 0 (completely
healthy) to 8 (completely rotten) according to the description
by Huang et al. (2011). Disease severity index (DSI) was then
calculated using the following formula:









Where n represents the rating scale (0–8) and Sn represents the
number of strawberries corresponding to the rating scale n. This
experiment was repeated two more times.
Determination of Phytotoxicity
The strawberry seedlings (Fragaria × ananassa cultivar “Jing
Yu”) were trans-planted in a plastic tunnel (Length × Width
× Height, 29 × 6.5 × 2 m) in September 28 of 2016. The
plants were carefully managed (watering, weeding) as required.
The toxicity experiment was performed from December 11 of
2016 to December 25 of 2016, when most strawberry plants
became bloomed. There were four treatments in this experiment:
(i) control (CK); (ii), (iii), and (iv) the crude extract of strain
3–10 (CE) at 10, 50, and 100 mg/ml, respectively. Twenty
strawberry plants for each treatment were randomly selected in
the field and the leaves on each selected plants were individually
immerged for 1 min either in 1% methanol (v/v) (CK) or in
each aqueous solution of CE. At 0, 1, 3, 7, and 14 days post
treatment (dpt), the treated plants were observed for the toxicosis
symptoms on the leaves (yellowing, necrosis and malformation
on leaves and flowers). Three plants for each treatment were
randomly selected and the three leaves on each treated plant were
detached as a leaf sample, one leaf from each plant. The leaves
were immediately taken to laboratory for determination of the
chlorophyll content (a, b and total). For chlorophyll extraction,
the three-leaf sample for each treatment was homogenized in
95% ethanol. The homogenate was centrifuged at 10,000× g
and the supernatant was transferred out for determination of
the absorbance values in DU730 Beckman spectrophotometer at
663 and 645 nm, respectively (Rout et al., 1998). The resulting
absorbance values A663 and A645 were used to calculate the
content of chlorophyll a (Chl a), chlorophyll b (Chl b) and the
total chlorophyll (Chl T) using the following formula:
Chl a (mg/g. F.W.)= [12.72× A663 − 2.59× A645]× V/W
Chl b (mg/g. F.W.)= [22.88× A645 − 4.67× A663]× V/W
Chl T (mg/g. F.W.)= [20.29× A645 + 8.05× A663]× V/W
where V represents volume of 95% ethanol used for chlorophyll
extraction in homogenization; W represents weight of the leaf
sample; F. W. represent fresh weight of the leaf sample.
Additionally, at 0 or 14 dpt, five other plants for each
treatment were randomly selected, uprooted and again taken to
laboratory. They were washed under the running tap water and
dried in an oven at 50◦C. The upper part of that plant (the roots
were trimmed) was then weighed.
Morphological and Physiological
Characterization
Streptomyces sp. 3–10 was streak-inoculated on various agar
media (Tables S2, S5). The cultures were incubated at 28◦C in
the dark for 14 days for observation of the colony morphology
(shape, size, color of the substrate mycelium and the aerial
mycelium, soluble pigments in media). For morphological
observation of the substrate mycelium, a sterilized glass slide
(7.5 × 2.5 × 0.1 cm, length × width × thickness) was placed
on a PDA culture of strain 3–10 at 28◦C for 14 days. Then,
the slide was removed from the culture, and the hyphae on the
slide were stained with 1% methyl green and observed under
a compound light microscope (Ruan and Huang, 2011). For
observation of the spore morphology, a sterilized cellophane
film was placed on PDA. Strain 3–10 was inoculated on the
cellophane film and the culture was incubated at 28◦C for 14
days. Then, the cellophane film was removed, and cut to small
pieces (approximately 3 × 3 mm, length × width). The resulting
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film pieces with the colonies of strain 3–10 were immediately
fixed in the glutaraldehyde fixative, followed by dehydration with
ethanol, drying in a Critical Point Dryer (Model: 13200E-AB,
SPI SUPPLIES, West Chester, PA, USA), and gold-coating in
a sputter coater (Model: JFC-1600, NTC, Tokyo, Japan) using
the conventional procedures. Finally, the specimens on the film
pieces were observed under a scanning electron microscope
(Model: JSM-6390/LV, NTC, Tokyo, Japan). To characterize
physiological features, strain 3–10 was inoculated on specific
media (Tables S2, S6, S7) using related procedures described by
Ruan and Huang (2011).
Phylogenetic Analysis
Streptomyces sp. 3–10 was shake-incubated at 28◦C for 2 days
in the liquid ISP-2 medium (Table S2). The mycelia in the
cultures were harvested by centrifugation at 7,000 × g for 5min.
Genomic DNA (gDNA) was extracted from the mycelium using
the reagents in the Wizard R© Genomic DNA Purification Kit
(Promega, Madison, WI, USA). It was used as template in
PCR for amplification of the 16S rDNA sequence using the
universal primers 27f (5′-AGAGTTTGATCCTGGCTCAG-3′)
and 1492r (5′-TACGGCTACCTTGACGACTT-3′; Zhang et al.,
2016). The 25-µl PCR reaction system contained 1µl of gDNA
(approximately 50 ng), 2.5 U Taq DNA polymerase (TaKaRa
Biotechnol. Co., Ltd., Dalian, China), 2.5µl 10× PCR buffer,
1µl of each primer (20µmol) and 0.5µl of dNTPs mixture (10
mmol/L). The PCR was performed in a S1000TM thermal cycler
(Bio-Rad, USA) with the following thermal program: initial
denaturation at 95◦C for 5 min, followed by 35 cycles (95◦C for
30 s, 56◦C for 30 s, 72◦C for 1.5 min), and final extension at
72◦C for 5 min. The resulting PCR product was purified from
the agarose gel after electrophoresis and cloned into the pMD18-
T vector (TaKaRa Biotechnol Co. Ltd., Dalian, China), which
was subsequently transformed into E. coli DH5α. A positive E.
coli clone with the correct DNA insert size was sequenced at
Sangon Biotechnol. Co. Ltd. (Shanghai, China). The sequence
was submitted to GenBank at NCBI and was assigned with the
accession number KX811537.
For phylogenetic analysis, a dataset was established based on
the 16S rDNA sequences of Streptomyces sp. 3–10, 39 other taxa
of Streptomyces species, and strain DSM44928 of Catenulispora
acidiphila (Table S4). They were aligned using the Clustal W
program in the MEGA 7.0 software and phylogenetic analysis
was done based on the alignment using the maximum likelihood
(ML) methods. All the nucleotides in the DNA sequences were
treated as un-ordered and un-weighted, and the gaps were treated
as the missing data. The bootstrap consensus trees were inferred
from 1,000 replicates.
Statistical Analysis
Data on spore germination rate, length of germ tubes, disease
incidence and disease severity index in related experiments
were separately analyzed for ANOVA (analysis of variance)
using the PROC ANOVA procedure (SAS Institute, Cary, NC,
USA, version 8.0, 1999). Treatment means in each experiment
were separated using Least significance Different (LSD) test
at α = 0.05. Before ANOVA, the percentage data on spore
germination rate and disease incidence were transformed to
numerical data by multiplication with 100. After analysis, the
data were back-transformed to the percentage values. Data on
content of chlorophyll a, chlorophyll b, the total chlorophyll and
dry weight of strawberry plant between the treatments of control
and the crude extract of Streptomyces sp. 3–10 was compared at
α= 0.05 using the PROC TTEST in the SAS software.
RESULTS
Antifungal Spectrum of the Crude Extract
The crude extract from Streptomyces sp. 3–10 showed a wide
antifungal spectrum (Table 1). It inhibited mycelial growth of
two species of Pythium and 20 species of fungi. The percentages
of inhibition of mycelial growth varied greatly among the target
species, ranging from 16.6 to 97.2% at 1µg/ml, and from 45.8
to 100% at 5µg/ml. Among the 20 fungal species, M. hiemails,
B. cinerea, R. stolonifer, and S. sclerotiorum are the causal agents
of strawberry fruit rot. They were inhibited by 80.8, 86.0, 91.4,
and 97.2%, respectively, at 1µg/ml, and by the rates higher than
97% at 5µg/ml (Table 1). In contrast, the crude extract weakly
inhibited (<10%) mycelial growth of Fusarium graminearum
(the causal agent of wheat head blight) and Pyricularia oryzae
(the causal agent of rice blast) at two concentrations (Table 1).
Results from the antibacterial experiment showed that the
crude extract of Streptomyces sp. 3–10 had no antibacterial
activity (Figure S1). It failed even at 100µg/ml to inhibit growth
and proliferation of all the four investigated bacteria, including
Acidovorax citrulli (the causal agent of watermelon bacterial fruit
blotch), Curtobacterium flaccumfaciens pv. flaccumfaciens (the
causal agent of bacterial wilt of beans), and Erwinia carotovora
(the causal agent of potato soft rot), and Bacillus subtilis (a
saprophyte).
Suppression of Fungal Spore Germination
by the Crude Extract
The crude extract effectively inhibited spore germination
of B. cinerea and R. stolonifer in GA at 20◦C (Table 2).
For B. cinerea, the inhibitory efficacy depended greatly on
concentration of the crude extract. In the treatments of the crude
extract at 1 and 5µg/ml, the conidia germinated by 93–99% at 6–
12 h post-incubation (hpi), not significantly different (P > 0.05)
from the germination rate of 99% in the control treatment. The
average values of germ-tube length reached 146.6 and 106.5µm
for the two concentrations of the crude extract, respectively. In
the treatments of the crude extract at 10, 50, and 100µg/ml, the
percentages of germinated conidia at 12 hpi were reduced by
12, 90, and 99%, respectively, and the average germ tube length
was reduced by 51, 89, and 92%, respectively, compared to the
control treatment (Table 2). For R. stolonifer, while the control
treatment had percentages of germinated sporangiospores of 0,
8.3 and 63.1% at 6, 9, and 12 hpi, respectively, and the average
germ-tube length reached 67.4µm at 12 hpi, the treatments
of the crude extract at 1, 5, 10, 50, and 100µg/ml completely
inhibited sporangiospore germination at 6, 9, and 12 hpi, just as
the fungicide treatment with captan at 100µg a.i./ml (Table 2).
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TABLE 2 | Effect of the crude extract (CE) of the antifungal substances
produced by Streptomyces sp. 3–10 on spore germination and germ tube
extension of conidia of B. cinerea and sporangiospores of R. stolonifer
(20◦C, GA).
Fungus Treatmenta Spore germination (%) Length of germ
tubes (µm, 12 hpi)
6 hpib 9 hpi 12 hpi
B. cinerea Control 95.1 ac 96.6 a 98.7 a 147.3 a
CE 1µg/ml 94.5 a 95.7 a 98.8 a 146.6 a
CE 5µg/ml 93.5 a 96.5 a 98.2 a 106.5 b
CE 10µg/ml 39.3 b 81.5 b 86.7 b 72.3 c
CE 50µg/ml 7.5 c 10.9 c 9.9 c 17.0 d
CE 100µg/ml 0.8 d 0.9 d 1.0 d 11.4 d
Pyrimethanil
100µg a.i./ml
0.8 d 0.9 d 1.1 d 9.3 d
LSD (0.05) 2.2 1.7 2.4 7.9
R. stolonifer Control 0.0 a 8.3 a 63.1 a 67.4 a
CE 1µg/ml 0.0 a 0.0 b 0.0 b 0.0 b
CE 5µg/ml 0.0 a 0.0 b 0.0 b 0.0 b
CE 10µg/ml 0.0 a 0.0 b 0.0 b 0.0 b
CE 50µg/ml 0.0 a 0.0 b 0.0 b 0.0 b
CE 100µg/ml 0.0 a 0.0 b 0.0 b 0.0 b
Captan 100µg
a.i./ml
0.0 a 0.0 b 0.0 b 0.0 b
LSD (0.05) 0.0 0.3 4.6 3.2
apH-values in GA alone, and in GA amended with the crude extract of Streptomyces sp.
3–10 at 1, 5, 10, 50, and 100µg/ml were 5.8, 5.9, 5.8, 5.4, 4.8, and 4.6, respectively.
bhpi, hours post-incubation.
cMeans within the same column for each fungus followed by the same letter are not
significantly different (P > 0.05) according to least significance test.
Chemical Identity of the Purified
Compounds
Two compounds (Nos. 1 and 2) were purified from the crude
extract. CompoundNo. 1 is a white amorphous powder. ESI±MS
(100 kV) of this compound showed a molecular ion peak at
m/z 683 (M+Na)+, 659 (M−H)− and HR-ESI (positive) MS at
m/z 683.3394 (M+Na)+ (calc., 683.3047). Based on these data,
the molecular formula of this compound was inferred to be
C36H52O11. The UV-Vis spectrum in methanol gave the UV
maximum absorbance at 237.9 nm (Figure S2). The 1H-NMR
spectrum (CD3OD, 400 MHz; Figure S3) showed five methyl
protons at δH 2.26 (3H, s), 1.75 (3H, s), 1.08 (3H, d, J = 6.8
Hz), 0.85 (3H, t, J = 6.9 Hz), and 0.79 (3H, d, J = 5.6 Hz), eight
olefinic protons at δH 6.97 (1H, dd, J = 15.7, 7.7 Hz), 6.44 (2H,
m), 6.25 (1H, d, J = 15.6 Hz), 5.88 (1H, s), 5.81 (1H, d, J = 15.7
Hz), 5.59 (1H, t, J = 7.0 Hz), and 5.53 (1H, dd, J = 15.6, 7.3 Hz),
and three oxymethine protons at δH 4.62 (1H, d, J = 7.3 Hz),
4.07 (1H, m), and 3.45 (1H, m; Table 3). The 13C NMR spectrum
(CD3OD, 100 MHz; Figure S4) showed 36 signals, including five
methyl groups at δC 14.6, 15.3, 13.0, 18.0, and 14.2, 10 methylene
carbons at δC 32.7, 28.7, 36.9, 35.2, 25.4, 34.8, 23.8, 23.4, 31.2,
and 29.9, eight olefinic carbons at δC 122.7, 152.6, 127.9, 137.8,
129.5, 134.1, 139.3, and 121.9, two methine carbons at δC 44.1
and 36.3, two olefinic quaternary carbons at δC 135.5 and 152.2,
TABLE 3 | 1H and 13C NMR spectra of reveromycins A and B from
Streptomyces sp. 3–10.
Reveromycin A Reveromycin B
Position δH [m, J(Hz)] δC Position δH [m, J(Hz)] δC
1 170.3 1 170.4
2 5.81, d (15.7) 122.7 2 5.79, d (15.6) 121.2
3 6.97, dd (15.7, 7.7) 152.6 3 6.99, dd (15.8, 7.5) 152.9
4 2.52, m 44.1 4 2.51, m 44.0
5 4.07, m 76.9 5 4.08, dd (7.4, 5.4) 77.1
6 5.53, dd (15.6, 7.3) 127.9 6 5.47, dd (15.7, 7.6) 127.2
7 6.25, d (15.6) 137.8 7 6.39, d (15.7) 138.6
8 135.5 8 135.2
9 5.59, t (7.0) 129.5 9 5.77, m 130.9
10 2.40, m 32.7 10 2.57, m 32.6
2.33, m 2.17, m
11 3.45, m 76.3 11 3.45, m 78.5
12 1.39, m 36.3 12 1.38, m 35.7
13 1.46, m 28.7 13 1.61, m 30.3
14 1.72, m 36.9 1.51, m
1.46, m 14 1.72, m 35.3
15 97.0 15 108.6
16 1.84, m 35.2 16 1.99, m 39.8
1.60, m 1.80, m
17 2.31, m 25.4 17 1.99, m 32.9
2.02, td (13.6, 4.0) 1.84, m
18 84.2 18 88.8
19 4.62, d (7.3) 79.7 19 5.57, d (3.7) 80.4
20 6.44, m 134.1 20 6.24, dd (16.0, 3.8) 132.6
21 6.44, m 139.3 21 6.28, d (16.1) 136.1
22 152.2 22 152.5
23 5.88, s 121.9 23 5.78, s 122.5
24 170.4 24 170.2
25 1.84, m 34.8 25 1.59, m 35.6
1.68, m 1.47, m
26 1.25, m 23.8 26 1.31, m 26.6
1.23, m
27 1.27, m 23.4 27 1.31, m 24.4
1.22, m
28 0.85, t (6.9) 14.6 28 0.92, t (6.9) 14.5
4-Me 1.08, d (6.8) 15.3 4-Me 1.01, d (6.9) 15.1
8-Me 1.75, s 13.0 8-Me 1.74, s 12.7
12-Me 0.79, t (5.6) 18.0 12-Me 0.89, d (6.5) 18.2
22-Me 2.26, s 14.2 22-Me 2.24, s 14.0
1′ 173.4 1′ 173.1
2′ 2.59, m 31.2 2′ 2.60, m 30.4
3′ 2.59, m 29.9 3′ 2.52, m 29.8
4′ 176.2 4′ 175.9
four oxymethine carbons at δC 76.9, 76.3, 84.2, and 79.7, three
carboxyl carbonyl carbons at δC 170.3, 170.4, and 176.2, one
ester carbonyl carbon at δC 173.4, and one quaternary spiroketal
carbon at δC 97.0 (Table 3). Compound No. 1 was identified as
reveromycin A (Figure 1) by comparing the data on the spectra
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of 1H NMR, 13C NMR, MS and UV-Vis of this compound with
the related spectra of reveromycin A reported by Fremlin et al.
(2011). The average content of reveromycin A in the crude extract
of strain 3–10 was 37.7% (Figure S5).
Compound No. 2 was also a white amorphous powder.
ESI±MS (100 kV) of this compound had a molecular ion peak
at m/z 683 (M+Na)+, 659 (M−H)−, HR-ESI (positive) MS at
m/z 683.3041 (M+Na)+ (calc., 683.3047). Based on these data,
the molecular formula of this compound was inferred to be
C36H52O11. The UV spectrum in methanol gave a UVmaximum
absorbance at 238.9 nm (Figure S6). The 1H-NMR spectrum
(CD3OD, 400 MHz; Figure S7) showed five methyl protons at δH
2.24 (3H, s), 1.74 (3H, s), 1.01 (3H, d, J = 6.9 Hz), 0.92 (3H, t,
J = 6.9 Hz) and 0.89 (3H, d, J = 6.5 Hz), eight olefinic protons at
δH 6.99 (1H, dd, J = 15.8, 7.5 Hz), 6.39 (1H, d, J = 15.7 Hz), 6.28
(1H, d, J = 16.1 Hz), 6.24 (1H, dd, J = 16.0, 3.8 Hz), 5.79 (1H, d, J
= 15.6 Hz), 5.78, (1H, s), 5.77 (1H, m), 5.47 (1H, dd, J = 15.7, 7.6
Hz), and three oxymethine protons at δH 5.57 (1H, d, J = 3.7 Hz),
4.08 (1H, dd, J = 7.4, 5.4 Hz), 3.45, (1H, m; Table 3). The 13C
NMR spectrum (CD3OD, 100 MHz; Figure S8) also showed 36
signals, including five methyl groups at δC 14.5, 15.1, 12.7, 18.2,
and 14.0, 10 methylene carbons at δC 32.6, 30.3, 35.3, 39.8, 32.9,
35.6, 26.6, 24.4, 30.4, and 29.8, eight olefinic carbons at δC 121.2,
152.9, 127.2, 138.6, 130.9, 132.6, 136.1, and 122.5, two methine
carbons at δC 44.0 and 35.7, two olefinic quaternary carbons at δC
135.2 and 152.5, four oxymethine carbons at δC 77.1, 78.5, 88.8,
and 80.4, three carboxyl carbonyl carbons at δC 170.4, 170.2, and
175.9, one ester carbonyl carbon at δC 173.1 and one quaternary
spiroketal carbon at δC 108.6 (Table 3). Compound No. 2 was
identified as reveromycin B (Figure 1) by comparing the data
on the spectra of 1H NMR, 13C NMR, MS, and UV-Vis of this
compound with related spectra of reveromycin B reported by
Fremlin et al. (2011).
Antifungal Activity of the Purified
Compounds
Reveromycins A and B from Streptomyces sp. 3–10 effectively
suppressed mycelial growth of B. cinerea, M. hiemails,
FIGURE 1 | Chemical structures of reveromycins A and B produced by
Streptomyces sp. 3–10.
R. stolonifer, and S. sclerotiorum, and spore germination
of B. cinerea, M. hiemails, and R. stolonifer (Table 4). The
suppressive efficacy was greatly affected by ambient pH. For
reveromycin A, the EC50-values ranged from 0.10 to 0.88µg/ml
at pH 4.5, from 0.42 to 1.76µg/ml at pH 5.5, and from 14.04
to 53.35µg/ml at pH 7.0. For reveromycin B, the EC50-values
ranged from 1.15 to 5.49µg/ml at pH 4.5, from 6.12 to
35.46µg/ml at pH 5.5, and>100µg/ml at pH 7.0.
Control Efficacy against Strawberry Fruit
Rot
At 3–7 days post inoculation (20◦C), the strawberries in the
control treatment were severely diseased (Figure 2, Table 5).
The percentages of diseased strawberries reached 100, 88.9,
100, and 94.4% for the control inoculations with B. cinerea,
M. hiemails, R. stolonifer, and S. sclerotiorum, respectively. The
disease severity index values reached 78.5, 62.5, 88.1, and 82.6
in these treatments, respectively. In contrast, most strawberries
in the treatments of the crude extract and reveromycin A from
strain 3–10 at 10, 50, and 100µg/ml, as well as in the treatments
of the fungicides at 10, 50, and 100µg a.i./ml appeared healthy
(Figure 2, Table 5). The percentages of diseased strawberries
were lower than 40% and the disease severity index values were
lower than 35 in these treatments. Reveromycin A at 50 and
100µg/ml completely suppressed strawberry fruit rot caused by
all the four fungi. Statistical analysis indicated that for each
pathogen, the treatments of the CE, reveromycin A and fungicide
differed significantly (P < 0.05) from the control treatment both
in disease incidence and in disease severity index. Under the
same concentration, the crude extract and reveromycin A from
strain 3–10 did not significantly (P > 0.05) differ from the
corresponding fungicide.
Phytotoxicity
The treatments of the strawberry leaves with the crude extract
of Streptomyces sp. 3–10 at 10, 50 and 100µg/ml did not
produce any visible toxic symptoms (yellowing, necrosis and
malformation) on leaves and flowers (Figure S9). They grew
normally and did not significantly differ (P > 0.05) from the
control treatment (water) both in leaf chlorophyll content and
in dry weight of the upper part of strawberry plants.
Taxonomic Identity of Streptomyces sp.
3–10
Streptomyces sp. 3–10 grew and sporulated on nine agar media
(BM, GS-1, ISP-1, ISP-2, ISP-3, ISP-5, ISP-6, ISP-7, PDA) after
incubation at 28◦C for 14 days with formation of whitish to
grayish colonies. They hardly grew on the ISP-4 medium (Figure
S10, Table S5). In the PDA cultures, the single colonies of
Streptomyces sp. 3–10 were averagely sized by 1.6 ± 0.3 mm
in diameter, dome-shaped in the colony center, and the saw
tooth-shaped at the colony margin (Figure S11). The substrate
mycelium was pale yellowish to orange in color and the aerial
mycelium was whitish to grayish in color (Figure S11). The
spore chains were rectiflexible in shape with the spores being
short rod in shape, 0.9 × 0.6µm (length × width) in size, and
smooth surfaced (Figure S11). The cultural and morphological
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TABLE 4 | 50% effective concentrations (EC50) of reveromycins A and B produced by Streptomyces sp. 3–10 against B. cinerea,M. hiemails, R. stolonifer,
and S. sclerotiorum.
Fungus Reveromycin A (Means ± S.D., µg/ml) Reveromycin B (Means ± S.D., µg/ml)
pH 4.5 pH 5.5 pH 7.0 pH 4.5 pH 5.5 pH 7.0
EC50 FOR MYCELIAL GROWTH
a
B. cinerea 0.88 ± 0.01 1.76 ± 0.07 53.35 ± 1.01 5.37 ± 0.11 30.60 ± 0.87 >100.00
M. hiemails 0.74 ± 0.02 1.49 ± 0.05 21.31 ± 0.32 4.07 ± 0.18 22.12 ± 0.11 >100.00
R. stolonifer 0.67 ± 0.03 1.45 ± 0.08 21.45 ± 3.62 4.48 ± 0.04 24.61 ± 0.35 >100.00
S. sclerotiorum 0.65 ± 0.02 1.27 ± 0.04 34.03 ± 0.44 5.49 ± 0.13 35.46 ± 3.92 >100.00
EC50 FOR SPORE GERMINATION
b
B. cinerea 0.57 ± 0.01 1.45 ± 0.03 49.33 ± 2.11 4.01 ± 0.09 23.62 ± 0.18 >100.00
M. hiemails 0.11 ± 0.01 0.45 ± 0.01 15.17 ± 0.56 1.59 ± 0.03 8.03 ± 0.21 >100.00
R. stolonifer 0.10 ± 0.01 0.42 ± 0.01 14.04 ± 0.61 1.15 ± 0.01 6.12 ± 0.11 >100.00
aThe cultures on reveromycin A- or reveromycin B-amended PDA were incubated at 20◦C for 24 h for R. stolonifer, whereas for 72 h for B. cinerea, M. hiemails and S. sclerotiorum.
bThe cultures with the conidia of B. cinerea, and sporangiospores of M. hiemails and R. stolonifer on GA were incubated at 20◦C for 12 h.
characteristics of Streptomyces sp. 3–10 matched the description
for Streptomyces yanglinensis 1307T (Xu et al., 2006).
Results of the physiological determination showed that strain
3–10 was similar to S. yanglinensis 1307T in most of the
measured features, but differed from S. yanglinensis 1307T
in utilization of myo-inositol, growth response to pH 3.5,
degradation of Tween 80 and sensitivity to streptomycin sulfate
and sulfamethoxazole. Strain 3–10 could utilize myo-inositol,
whereas strain 1307T could not. Strain 3–10 could grow on ISP-
3 at pH 3.5, whereas strain 1307T could not. Strain 3–10 could
not degrade Tween 80, whereas strain 1307T could. Strain 3–10
showed sensitive to streptomycin sulfate (10µg/ml), but resistant
to sulfamethoxazole (25µg/ml). In contrast, strain 1307T showed
resistant to streptomycin sulfate (10µg/ml), but sensitive to
sulfamethoxazole (25µg/ml; Tables S6, S7).
The close relationship between Streptomyces sp. 3–10 and
S. yanglinensis 1307T was further confirmed by phylogenetic
analysis of the 16S rDNA sequences. Streptomyces sp. 3–10 is
distantly related to strains F-1, JCM4662T and NRBC13818T
of S. platensis, but is closely related to S. yanglinensis 1307T
(Figure 3). Therefore, Streptomyces sp. 3–10 might represent a
novel phylotype of S. yanglinensis.
DISCUSSION
Reveromycins are spiroacetal polyketide compounds produced
by Streptomyces species (Osada et al., 1991; Koshino et al.,
1992; Takahashi et al., 1992a,b; Fremlin et al., 2011). So far,
three strains of Streptomyces have been reported to produce
reveromycins. They are strain SN-593 of S. reveromyceticus
isolated from a soil sample in Japan (Osada et al., 1991;
Koshino et al., 1992; Takahashi et al., 1992a,b), and strains MST-
MA568 and MST-RA7781 of Streptomyces spp. isolated from a
sediment sample and a soil sample, respectively, in Australia
(Fremlin et al., 2011). Fremlin et al. (2011) reported that the
frequency of reveromycins-producing actinomycete isolates is
very low. Two (e.g., MST-MA568 and MST-RA7781) out of
400,000 actinomycete isolates were found to be able to produce
reveromycins (Fremlin et al., 2011). The present study found
that Streptomyces sp. 3–10 can produce reveromycins A and B.
This finding enriched the reveromycins-producing Streptomyces
resource and will be important for further exploitation of
the Streptomyces-derived reveromycins for pharmaceutical and
agricultural use in the future.
Biological activities of reveromycin A have been well
elucidated in previous studies (Osada, 2016). It is a
multifunctional chemical, owning strong capabilities to
inhibit mitogenic activity induced by epidermal growth factor
(Osada et al., 1991), to suppress hormone-dependent tumors
like ovarian cancer and prostate (Takahashi et al., 1997), to
alleviate osteoporosis by inducing apoptosis specifically in
osteoclasts (Woo et al., 2006), and to inhibit proliferation
of Candida species (Takahashi et al., 1992b; Fremlin et al.,
2011). Miyamoto et al. (2002) found that the molecular target
of reveromycin A in Saccharomyces cerevisiae is isoleucyl-
transfer RNA (tRNA) synthetase. Although Osada et al. (1991)
indicated that reveromycin A has antifungal activity against plant
pathogenic fungi with the minimum inhibitory concentration
ranging from 16 to 64µg/ml. However, detailed information
about the inhibited plant pathogenic fungi was not mentioned
in that report (Osada et al., 1991). Therefore, whether or not
reveromycin A and other reveromycin analogs can inhibit
plant pathogens like B. cinerea, M. hiemails, R. stolonifer,
and S. sclerotiorum, and Oomycetes such as like species of
Pythium remains unknown. Fremlin et al. (2011) reported that
reveromycins A to M had antifungal activity against Candida
species. They did not report the antifungal activity of these
reveromycins against plant pathogenic fungi.
In this study, we found that the crude extract from
Streptomyces sp. 3–10 at 5µg/ml had a wide antifungal spectrum,
including many important plant pathogens such as, B. cinerea,
M. hiemails, R. stolonifer, and S. sclerotiorum (Table 1). We
also demonstrated that the crude extract and reveromycin A
from Streptomyces sp. 3–10 at 10, 50, and 100µg/ml was
highly effective in suppression of strawberry fruit rot caused
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FIGURE 2 | Efficacy of the crude extract, reveromycin A from Streptomyces sp. 3–10 and fungicides in suppression of strawberry fruit rot caused by
Botrytis cinerea (Bc), Mucor hiemails (Mh), Rhizopus stolonifer (Rs), and Sclerotinia sclerotiorum (Ss). B. cinerea, M. hiemails, and R. stolonifer were
inoculated with spores. S. sclerotiorum was inoculated with mycelial agar plugs. The strawberries were maintained at 20◦C under humid conditions for 3 days for R.
stolonifer, 5 days for M. hiemails, and 7 days for B. cinerea and S. sclerotiorum.
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TABLE 5 | Efficacy of the crude extract (CE) and reveromycin A (RA) from Streptomyces sp. 3–10 in suppression of strawberry fruit rot caused by
B. cinerea, M. hiemails, R. stolonifer, and S. sclerotiorum in comparison with respective fungicides.
Treatment a B. cinerea M. hiemails R. stolonifer S. sclerotiorum
DIb DSIb DI DSI DI DSI DI DSI
Control 100.0 ac 78.5 a 88.9 a 62.5 a 100.0 a 88.1a 94.4 a 82.6 a
CE 10µg/ml 22.2 b 4.9 b 11.1 c 8.3 cd 27.7 b 7.6 c 5.6 b 1.4 b
CE 50µg/ml 11.1 bc 4.2 b 5.6 c 2.1 de 11.1 c 2.8 d 0.0 b 0.0 b
CE 100µg/ml 0.0 c 0.0 c 0.0 c 0.0 e 0.0 c 0.0 d 0.0 b 0.0 b
RA 10µg/ml 22.2 b 4.2 b 11.1 c 2.1 e 11.1 c 2.7 d 0.0 b 0.0 b
RA 50µg/ml 0.0 c 0.0 c 0.0 c 0.0 e 0.0 c 0.0 d 0.0 b 0.0 b
RA 100µg/ml 0.0 c 0.0 c 0.0 c 0.0 e 0.0 c 0.0 d 0.0 b 0.0 b
FU 10µg a.i./ml 11.1 bc 3.5 bc 27.7 b 34.7 b 38.8 b 22.8 b 5.6 b 2.1 b
FU 50µg a.i./ml 5.6 c 2.1 bc 11.1 c 10.4 c 11.1 c 3.5 cd 0.0 b 0.0 b
FU 100µg a.i./ml 0.0 c 0.0 c 0.0 c 0.0 e 0.0 c 0.0 d 0.0 b 0.0 b
LSD (0.05) 11.6 3.9 12.7 6.3 11.6 4.6 9.0 2.4
aFungicides (FU): Pyrimethanil for B. cinerea, captan for M. hiemails and R. stolonifer, and dimetachlone for S. sclerotiorum.
bDI, Disease incidence (%); DSI, Disease severity index (0–100).
cMeans within the same column followed by the same letter are not significantly different (P > 0.05) according to least significance test.
by these pathogens and the efficacy was comparable to that
of the corresponding commercial fungicides (Table 5). It is
well recognized that B. cinerea, M. hiemails, R. stolonifer, and
S. sclerotiorum are the necrotrophic plant pathogens. They
can aggressively infect mature strawberry fruit under cool and
humid conditions, thereby causing severe economic losses for
strawberry production. Nowadays, control of B. cinerea as well
as three other fungi depends largely on repeated application of
fungicides. In most cases, the fungicide application can suppress
infection by these fungi. However, frequent application of the
fungicides may cause some undesirable side effects, such as
fungicide residues in strawberry fruit, pollution to environment,
and development of fungicide-resistant fungal strains. The results
about the wide antifungal spectrum and high antifungal activity
for themetabolites of Streptomyces sp. 3–10 suggest that they have
a promising potential to be exploited for control of strawberry
fruit rot caused by these four fungi. This study found that the
crude extract of Streptomyces sp. 3–10 at 10, 50 and 100µg/ml
did not produce any visible toxic symptoms on leaves of
strawberry (Figure S9). This result suggests that application of the
metabolites of Streptomyces sp. 3–10 on strawberry plants at the
flowering stage might be a safe measure for control of strawberry
fruit rot.
Among the fungi and Oomycetes inhibited by the metabolites
from Streptomyces sp. 3–10, Fusarium oxysporum, Pythium
apanidermatum, P. ultimum, Rhizoctonia solani, Sclerotium
rolfsii, Sclerotinia minor, and S. sclerotiorum are soilborne plant
pathogens. Antifungal activity against these organisms suggests
that inoculation of Streptomyces sp. 3–10 into soil may yield
suppressive effect on these organisms. This study found that
Streptomyces sp. 3–10 can grow at pH 3.5 and 4.5, but failed
to grow at pH 7.5 (Table S6). This acidophilic characteristic of
Streptomyces sp. 3–10 may help it to adapt to the acidic soil
conditions in south of China. Moreover, this study found that the
antifungal activity of reveromycins A and B from Streptomyces
sp. 3–10 is high at pH 4.5 and 5.5, whereas is decreased at pH 7.0
(Table 4), implying that application of Streptomyces sp. 3–10 in
acidic soil may achieve high antifungal efficacy in suppression of
these soil-dwelling fungi.
Previous studies showed that many plant pathogenic fungi
such as B. cinerea and S. sclerotiorum can secrete oxalic acid
to facilitate their infection and colonization of plant tissues
(Choquer et al., 2007; Williams et al., 2011). Oxalic acid can
acidify the surrounding environment. In this study, we found that
reveromycins A and B from Streptomyces sp. 3–10 showed higher
antifungal activity at pH 4.5 than at pH 5.5 and 7.0 (Table 4).
Thus, the acidic environment created by oxalic acid produced
by B. cinerea and S. sclerotiorum may enhance the antifungal
activity of Streptomyces sp. 3–10 against the two pathogens. This
may be one of the reasons responsible for the high antifungal
activity of reveromycins A and B in inhibition of B. cinerea and
S. sclerotiorum.
Streptomyces sp. 3–10 was previously thought to be a mutant
S. platensis F-1, as it was isolated from a PDA culture of
strain F-1 treated with UV-C and LiCl (Che, 2011). Due to
the dramatic difference between strains 3–10 and F-1 in colony
morphology, this study tried to clarify the taxonomic status of
Streptomyces sp. 3–10. The results showed that strain 3–10 is
closely related to S. yanglinensis 1307T (possibly representing a
novel phylotype of S. yanglinensis), but is distantly related to S.
platensis F-1 (Figure 3). This result suggests that Streptomyces sp.
3–10 is probably a contaminant, rather than a derivative from
S. platensis F-1.
Streptomyces yanglinensis was established by Xu and
colleagues in 2006 with strain 1307T as the type strain (Xu et al.,
2006). Results of this study showed that strain 3–10 was similar
to strain 1307T in the majority of the measured physiological
characteristics, but is different from strain 1307T in utilization
of myo-inositol, in growth response to pH 3.5, in degradation of
Tween 80, as well as in sensitivity to streptomycin sulfate and
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FIGURE 3 | A maximum-likelihood tree showing the relationship
between Streptomyces sp. 3–10 and 39 other taxa of Streptomyces.
The phylogenetic tree was inferred based on 16S rDNA sequences with
Catenuliospora acidiphila as the out-group. The bootstrap values (n = 1,000)
higher than 50% are shown at the internodes in the tree. The NCBI GenBank
accession numbers are given in parentheses following the strain names. The
scale bar indicates 1% nucleotide substitution per site.
sulfamethoxazole (Tables S6, S7). Therefore, strain 3–10 may
represent a physiological type different from strain 1307T.
It is quite interesting that among the four reveromycins-
producing strains of Streptomyces (SN-593, MST-MA568, MST-
RA7781, 3–10) so far known, three strains of Streptomyces
(MST-MA568, MST-RA7781, 3–10) are closely related to
S. yanglinensis based on phylogeny of 16S rDNA sequences
(Figure 3; Fremlin et al., 2011). This result suggests that
S. yanglinensis-related species may have a conserved pathway
for biosynthesis of reveromycins. Several other strains of
S. yanglinensis from soil samples collected in China (e.g.,
strains 317, 913 and 1,307) were readily reported (Xu et al.,
2006). Whether or not they can produce reveromycins remains
unknown and additional studies are necessary to clarify this
point.
CONCLUSIONS
This study demonstrated that the crude extract of Streptomyces
sp. 3–10 could effectively inhibit mycelial growth of 22 species
of fungi and spore germination of B. cinerea, M. hiemails,
and R. stolonifer. Two antifungal compounds, reveromycins A
and B, were purified from the cultures of Streptomyces sp.
3–10. Both the crude extract of strain 3–10 and reveromycin
A purified from that strain showed high efficacy in suppression
of strawberry fruit rot caused by B. cinerea, M. hiemails, R.
stolonifer, and S. sclerotiorum. The efficacy was comparable to
that of corresponding commercial fungicides. The findings of
this study are useful for further exploitation of reveromycins to
control plant fungal diseases.
AUTHOR CONTRIBUTIONS
AL, HL, HC, LY designed research; AL and HL performed
research and analyzed the spectra of 1H NMR and 13C NMR; JZ
and MW provided new agents and analyzed the data; AL, WC,
and GL wrote the paper.
ACKNOWLEDGMENTS
This study was financially supported by China’s Special
Fund for Agro-scientific Research in the Public Interest
(201303025), China Agriculture Research System (CARS-
13), and the National Natural Science Foundation of China
(31571955). We appreciate the kind help from Prof. Z. Y. Wan
(National Engineering Research Center for Biopesticides, Hubei
Academy of Agricultural Sciences, Wuhan, China) for analysis of
the spectra of 1H NMR and 13C NMR.
SUPPLEMENTARY MATERIAL




Anitha, A., and Rabeeth, M. (2010). Degradation of fungal cell walls of
phytopathogenic fungi by lytic enzymes of Streptomyces griseus. Afr. J. Plant
Sci. 4, 61–66.
Beer, S. V., Rundle, J. R., and Norielli, J. L. (1984). Recent progress in the
development of biological control for fire blight-A, review. Acta Hortic. 151,
195. doi: 10.17660/ActaHortic.1984.151.24
Bérdy, J. (2012). Thoughts and facts about antibiotics: where we are now and where
we are heading. J. Antibiot. 65, 385–395. doi: 10.1038/ja.2012.27
Berg, G., Marten, P., Minkwitz, A., and Brückner, S. (2010). Efficient biological
control of plant fungal diseases by Streptomyces sp. DSMZ12424. J. Plant Dis.
Protect. 108, 1–10.
Bonev, B., Hooper, J., and Parisot, J. (2008). Principles of assessing bacterial
susceptibility to antibiotics using the agar diffusion method. J. Antimicrob.
Chemother. 61, 1295–1301. doi: 10.1093/jac/dkn090
Frontiers in Microbiology | www.frontiersin.org 12 April 2017 | Volume 8 | Article 550
Lyu et al. Antifungal Metabolites from Streptomyces sp. 3–10
Brzezinska, M. S., Jankiewicz, U., and Walczak, M. (2013). Biodegradation
of chitinous substances and chitinase production by the soil
actinomycete Streptomyces rimosus. Int. Biodeter. Biodegr. 84, 104–110.
doi: 10.1016/j.ibiod.2012.05.038
Chapman and Hall (2003). The Combined Chemical Dictionary on CD-ROM v 6.1.
Head FAST CD software.
Che, H. J. (2011). Mutation Improvement of Streptomyces platensis F-1 and the
Biocontrol Potential Assessment of Mutant Strains. [Master thesis]. Wuhan:
Huazhong Agricultural University.
Chen, Y. Y., Chen, P. C., and Tsay, T. T. (2016). The biocontrol efficacy
and antibiotic activity of Streptomyces plicatus on the oomycete
Phytophthora capsici. Biol. Control 98, 34–42. doi: 10.1016/j.biocontrol.2016.
02.011
Choquer, M., Fournier, E., Kunz, C., Levis, C., Pradier, J. M., Simon,
A., et al. (2007). Botrytis cinerea virulence factors: new insights into a
necrotrophic and polyphageous pathogen. FEMS Microbiol. Lett. 277, 1–10.
doi: 10.1111/j.1574-6968.2007.00930.x
Conn, V. M., Walker, A. R., and Franco, C. M. M. (2008). Endophytic
actinobacteria induce defense pathways in Arabidopsis thaliana. Mol. Plant
Microbe Interact. 21, 208–218. doi: 10.1094/MPMI-21-2-0208
Fremlin, L., Farrugia, M., Piggott, A. M., Khalil, Z., Lacey, E., and Capon,
R. J. (2011). Reveromycins revealed: new polyketide spiroketals from
Australian marine-derived and terrestrial Streptomyces spp. A case of natural
products vs. artifacts. Organ. Biomol. Chem. 9, 1201–1211. doi: 10.1039/C0OB
00654H
Guo, X. X., Liu, N., Li, X. M., Ding, Y., Shang, F., Gao, Y. S., et al. (2015).
Red soils harbor diverse culturable actinomycetes that are promising sources
of novel secondary metabolites. Appl. Environ. Microbiol. 81, 3086–3103.
doi: 10.1128/AEM.03859-14
Huang, R., Li, G. Q., Zhang, J., Yang, L., Che, H. J., Jiang, D. H., et al.
(2011). Control of postharvest Botrytis fruit rot of strawberry by volatile
organic compounds of Candida intermedia. Phytopathology 101, 859–869.
doi: 10.1094/PHYTO-09-10-0255
Kettleson, E., Kumar, S., Reponen, T., Vesper, S., Meheust, D., Grinshpun,
S. A., et al. (2013). Stenotrophomonas, Mycobacterium, and Streptomyces
in home dust and air: associations with moldiness and other
home/family characteristics. Indoor Air. 23, 387–396. doi: 10.1111/ina.
12035
Kim, B. S., and Hwang, B. K. (2007). Microbial fungicides in the control of
plant diseases. J. Phytopathol. 155, 641–653. doi: 10.1111/j.1439-0434.2007.
01314.x
Kim, B. Y., Willbold, S., Kulik, A., Helaly, S. E., Zinecker, H., and Wiese, J. (2011).
Elaiomycins, B., and C, novel alkylhydrazides produced by Streptomyces sp. BK
190. J. Antibiot. 64, 595–597. doi: 10.1038/ja.2011.53
Koshino, H., Takahashi, H., Osada, H., and Isono, K. (1992). Reveromycins, new
inhibitors of eukaryotic cell growth. III. Structures. J. Antibiot. 45, 1420–1427.
doi: 10.7164/antibiotics.45.1420
Kurth, F., Mailander, S., Bonn, M., Feldhahn, L., Herrmann, S., Große,
I., et al. (2014). Streptomyces-induced resistance against oak powdery
mildew involves host plant responses in defense, photosynthesis, and
secondary metabolism pathways. Mol. Plant Microbe Interact. 27, 891–900.
doi: 10.1094/MPMI-10-13-0296-R
Lehr, N. A., Schrey, S. D., Hampp, R., and Tarkka, M. T. (2008). Root
inoculation with a forest soil streptomycete leads to locally and systemically
increased resistance against phytopathogens in Norway spruce. New Phytol.
177, 965–976. doi: 10.1111/j.1469-8137.2007.02322.x
Mander, P., Cho, S. S., Choi, Y. H., Panthi, S., Choi, Y. S., Kim, H. M., et al.
(2016). Purification and characterization of chitinase showing antifungal and
biodegradation properties obtained from Streptomyces anulatus CS242. Arch.
Pharm. Res. 39, 878–886. doi: 10.1007/s12272-016-0747-3
Millard, W. A., and Taylor, C. B. (1927). Antagonism of microorganisms as the
controlling factor in the inhibition of scab by green-manuring. Ann. Appl. Biol.
14, 202–216. doi: 10.1111/j.1744-7348.1927.tb07076.x
Minuto, A., Spadaro, D., Garibaldi, A., and Gullino, M. L. (2006). Control
of soilborne pathogens of tomato using a commercial formulation of
Streptomyces griseoviridis and solarization. Crop Protect. 25, 468–475.
doi: 10.1016/j.cropro.2005.08.001
Miyamoto, Y., Machida, K., Mizunuma,M., Emoto, Y., Sato, N., Miyahara, K., et al.
(2002). Identification of Saccharomyces cerevisiae isoleucyl-tRNA synthetase as
target of G1-specific inhibitor reveromycin A. J. Biol. Chem. 277, 28810–28814.
doi: 10.1074/jbc.M203827200
Osada, H. (2016). Chemical and biological studies of reveromycin A. J. Antibiot.
69, 723–730. doi: 10.1038/ja.2016.57
Osada, O., Koshino, O., and Isono, K. (1991). Reveromycin A, a new antibiotic
which inhibits the mitogenic activity of epidermal growth factor. J. Antibiot.
44, 259–261. doi: 10.7164/antibiotics.44.259
Rout, N. P., Tripathi, S. B., and Shaw, P.W. (1998). Effect of salinity on chlorophyll
and proline contents in three aquatic macrophytes. Biol. Plant. 40, 453–458.
doi: 10.1023/A:1001186502386
Ruan, J. S., and Huang, Y. (2011). Rapid Identification and Systematics of
Actinobacteria. Beijing: Science Press.
Shakeel, Q., Lyu, A., Zhang, J., Wu, M. D., Chen, S. W., Chen, W. D., et al.
(2016). Optimization of the cultural medium and conditions for production
of antifungal metabolites by Streptomyces platensis 3–10 and evaluation of
its efficacy in suppression of clubroot disease (Plasmodiophora brassicae)
of oilseed rape. Biol. Control 101, 59–68. doi: 10.1016/j.biocontrol.2016.
06.007
Solans, M., Vobis, G., Cassan, F., Luna, V., and Wall, L. G. (2011). Production
of phytohormones by root-associated saprophytic actinomycetes isolated from
the actinorhizal plant Ochetophila trinervis. World J. Microbiol. Biotechnol. 27,
2195–2202. doi: 10.1007/s11274-011-0685-7
Supong, K., Thawaia, C., Choowong, W., Kittiwongwattana, C. C., Thanaboripat,
D., Laosinwattana, C., et al. (2016). Antimicrobial compounds from endophytic
Streptomyces sp. BCC72023 isolated from rice (Oryza sativa L.). Res. Microbiol.
167, 290–298. doi: 10.1016/j.resmic.2016.01.004
Takahashi, H., Osada, H., Koshino, H., Kudo, T., Amano, S., Shimizu, S., et al.
(1992a). Reveromycins, new inhibitors of eukaryotic cell growth I. Producing
organism, fermentation, isolation and physiochemical properties. J. Antibiot.
45, 1409–1413. doi: 10.7164/antibiotics.45.1409
Takahashi, H., Osada, H., Koshino, H., Sasaki, M., Onose, R., Nakakoshi,
M., et al. (1992b). Reveromycins, new inhibitors of eukaryotic cell growth
II. Biological activities. J. Antibiot. 45, 1414–1419. doi: 10.7164/antibiotics.
45.1414
Takahashi, H., Yamashita, Y., Takaoka, H., Nakamura, J., Yoshihama, M.,
and Osada, H. (1997). Inhibitory action of reveromycin A on TGF-alpha-
dependent growth of ovarian carcinoma BG-1 in vitro and in vivo. Oncol. Res.
9, 7–11.
Van Ewijk, P. H., and Hoekstra, J. A. (1993). Calculation of the EC50 and its
confidence interval when subtoxic stimulus is present. Ecotoxicol. Environ. Saf.
25, 25–32. doi: 10.1006/eesa.1993.1003
Wan, M. G., Li, G. Q., Zhang, J. B., Jiang, D. H., and Huang, H. C. (2008).
Effect of volatile substance of Streptomyces platensis F-1 on control of plant
fungal diseases. Biol. Control 46, 552–559. doi: 10.1016/j.biocontrol.2008.
05.015
Wan, Z. Y., Fang, W., Shi, L. Q., Wang, K. M., Zhang, Y. N., Zhang, Z. G.,
et al. (2015). Nononestmycins A and B, two new 32-membered bioactive
macrolides from Streptomyces phytohabitans HBERC-20821. J. Antibiot. 68,
186–190. doi: 10.1038/ja.2014.123
Williams, B., Kabbage, M., Min, J. Y., Britt, R., and Dickman, M. B. (2011).
Tipping the balance: Sclerotinia sclerotiorum secreted oxalic acid suppresses
host defenses by manipulating the host redox environment. PLoS Pathog.
7:e1002107. doi: 10.1371/journal.ppat.1002107
Woo, J. T., Kawatani, M., Kato, M., Shinki, T., Yonezawa, T., Kanoh, N., et al.
(2006). Reveromycin A, an agent for osteoporosis, inhibits bone resorption by
inducing apoptosis specifically in osteoclasts. Proc. Natl. Acad. Sci. U.S.A. 103,
4729–4734. doi: 10.1073/pnas.0505663103
Xu, C. G., Wang, L. M., Cui, Q. F., Huang, Y., Liu, Z. H., Zheng, G.
Y., et al. (2006). Neutrotolerant acidophilic Streptomyces species isolated
from acidic soils in China: Streptomyces guanduensis sp. nov., Streptomyces
paucisporeus sp. nov., Streptomyces rubidus sp. nov. and Streptomyces
yanglinensis sp. nov. Int. J. Syst. Evol. Microbiol. 56, 1109–1115. doi: 10.1099/ijs.
0.63959-0
Zacky, F. A., and Ting, A. S. Y. (2013). Investigating the bioactivity of cells
and cell-free extracts of Streptomyces griseus towards Fusarium oxysporum f.
Frontiers in Microbiology | www.frontiersin.org 13 April 2017 | Volume 8 | Article 550
Lyu et al. Antifungal Metabolites from Streptomyces sp. 3–10
sp. cubense race 4. Biol. Control 66, 204–208. doi: 10.1016/j.biocontrol.2013.
06.001
Zhang, B. H., Ding, Z. G., Li, H. Q., Mou, X. Z., Zhang, Y. Q., Yang,
J. Y., et al. (2016). Algicidal activity of Streptomyces eurocidicus
JXJ-0089 metabolites and their effects on Microcystis physiology.
Appl. Environ. Microbiol. 82, 5132–5143. doi: 10.1128/AEM.
01198-16
Zhang, D. J., Wei, G., Wang, Y., Si, C. C., Tian, L., Tao, L. M.,
et al. (2011). Bafilomycin K, a new antifungal macrolide from
Streptomyces flavotricini Y12-26. J. Antibiot. 64, 391–393. doi: 10.1038/ja.
2011.12
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Lyu, Liu, Che, Yang, Zhang, Wu, Chen and Li. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Microbiology | www.frontiersin.org 14 April 2017 | Volume 8 | Article 550
